Sodium-glucose cotransporter-2 inhibitors: where and when?

被引：1
|
作者：
Cowie, Martin R. [1 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, Royal Brompton Hosp, London, England
来源：
FUTURE CARDIOLOGY | 2020年 / 17卷 / 03期
关键词：
cardiovascular disease; chronic kidney disease; diabetes mellitus; guidelines; heart failure; implementation; outcome trials; SGLT2; inhibitors; REDUCED EJECTION FRACTION; HEART-FAILURE;
D O I：
10.2217/fca-2020-0207
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Tweetable abstract Sodium-glucose cotransporter-2 inhibitors not only improve glycaemic control in Type 2 diabetes mellitus but convincingly improve outcome for everyone with HFrEF and albuminuric kidney disease. Trials then license - now all we need is implementation
引用
收藏
页码：403 / 406
页数：4
相关论文
共 50 条
  • [21] Mortality Outcomes With Different Sodium-glucose Cotransporter-2 Inhibitors: Are They Dissimilar?
    Singh, Awadhesh Kumar
    ENDOCRINE PRACTICE, 2022, 28 (10) : 1107 - 1108
  • [22] Antifibrotic effects of sodium-glucose cotransporter-2 inhibitors: A comprehensive review
    Shakour, Neda
    Karami, Shima
    Iranshahi, Mehrdad
    Butler, Alexandra E.
    Sahebkar, Amirhossein
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (01)
  • [23] Potential Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in the Perioperative Period
    Hulst, Abraham H.
    Hermanides, Jeroen
    DeVries, J. Hans
    Preckel, Benedikt
    ANESTHESIA AND ANALGESIA, 2018, 127 (01): : 306 - 307
  • [24] Different Sodium-Glucose Cotransporter-2 Inhibitors: Can They Prevent Death
    Mukhopadhyay, Pradip
    Sanyal, Debmalya
    Chatterjee, Purushottam
    Pandit, Kaushik
    Ghosh, Sujoy
    ENDOCRINE PRACTICE, 2022, 28 (08) : 795 - 801
  • [25] Effect of sodium-glucose cotransporter-2 inhibitors on renal handling of electrolytes
    Meena, Priti
    Bhargava, Vinant
    Bhalla, Anil
    Rana, Devinder
    Mantri, Alok
    POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1154) : 819 - 824
  • [26] Sodium-glucose cotransporter-2 inhibitors in diabetes and inflammatory skin diseases
    Shen, Chin-Hsuan
    Yang, Yi-Sun
    Lee, Irene Tai-Lin
    Chiang, Meng-Han
    Chen, Steven T.
    Ma, Kevin Sheng-Kai
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (03) : 467 - 468
  • [27] The anti-hypertensive effects of sodium-glucose cotransporter-2 inhibitors
    Kugathasan, Luxcia
    Dubrofsky, Lisa
    Advani, Andrew
    Cherney, David Z. I.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2023, 21 (01) : 15 - 34
  • [28] Sodium-Glucose Cotransporter-2 Inhibitors and Lower-Extremity Amputation
    Aizawa, Yoshifusa
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 201 : 388 - 389
  • [29] Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis
    Shah, Tayyab
    Zhang, Zhiyuan
    Shah, Haashim
    Fanaroff, Alexander C.
    Nathan, Ashwin S.
    Parise, Helen
    Lutz, John
    Sugeng, Lissa
    Bellumkonda, Lavanya
    Redfors, Bjorn
    Omerovic, Elmir
    Petrie, Mark C.
    Vora, Amit N.
    Fiorilli, Paul N.
    Kobayashi, Taisei
    Ahmad, Yousif
    Forrest, John K.
    Giri, Jay S.
    Herrmann, Howard C.
    Lansky, Alexandra J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2025, 18 (06) : 738 - 748
  • [30] Sodium-Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction
    Profili, Nicia I.
    Castelli, Roberto
    Manetti, Roberto
    Sircana, Marta C.
    Pagni, Michela
    Sechi, Gemma Lisa
    Gidaro, Antonio
    Cossu, Costantino
    Bella, Francesco
    Delitala, Alessandro P.
    BIOMEDICINES, 2025, 13 (03)
12345